[Federal Register Volume 68, Number 34 (Thursday, February 20, 2003)]
[Notices]
[Pages 8299-8300]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-4089]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Contaminants and Natural Toxicants Subcommittee of the Food 
Advisory Committee; Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Contaminants and Natural Toxicants Subcommittee 
of the Food Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on March 18, 2003, from 8 
a.m. to 6 p.m.; and on March 19, 2003, from 8:30 a.m. to 3 p.m.
    Location: U.S. Department of Agriculture, Animal and Plant Health 
Inspection Service, 4700 River Rd., Conference Center, Riverdale, MD, 
301-734-8010.
    Contact Person: Jeanne E. Latham, Center for Food Safety and 
Applied Nutrition (HFS-800), Food and Drug Administration, 5100 Paint 
Branch Pkwy., College Park, MD 20740, 301-436-1756, or FDA Advisory 
Committee Information Line, 1-800-741-8138 301-443-0572 in the 
Washington, DC area), code 10564. Please call the Information Line for 
up-to-date information on this meeting.
    Agenda: The meeting's purpose is to discuss the scientific issues 
and principles involved in assessing and evaluating Enterobacter 
sakazakii contamination in powdered infant formula, risk reduction 
strategies based on available data, and research questions and 
priorities. To ensure the presence of the most relevant expertise, the 
membership of the subcommittee, which has expertise in contaminants, 
will be augmented by consultants with expertise in infant formula.
    The background material for this meeting will be posted on the 
Internet when available or one working day before the meeting at http:/
/www.cfsan.fda.gov/[sim]lrd/vidtel.html.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by March 3, 2003. 
Oral

[[Page 8300]]

presentations from the public will be scheduled between approximately 4 
p.m. and 5 p.m. on March 18, 2003. Time allotted for each presentation 
may be limited. Those desiring to make formal oral presentations should 
notify the contact person before March 13, 2003, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Persons attending FDA's advisory committee meetings are advised 
that the agency is not responsible for providing access to electrical 
outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Jeanne E. Latham at 
least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: February 10, 2003.
Linda Arey Skladany,
Associate Commissioner for External Relations.
[FR Doc. 03-4089 Filed 2-19-03; 8:45 am]
BILLING CODE 4160-01-S